Kentucky Trust Company’s Pfizer PFE Stock Holding History

Kentucky Trust Company’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.58M	Sell	65,411 -1,579	-2%	-$41.3K	0.76%	42
2026 Q1	$1.88M	Buy	66,990 +3,799	+6%	+$101K	0.99%	33
2025 Q4	$1.57M	Buy	63,191 +1,240	+2%	+$31.3K	0.83%	39
2025 Q3	$1.58M	Sell	61,951 -700	-1%	-$17.3K	0.85%	36
2025 Q2	$1.52M	Buy	62,651 +680	+1%	+$15.9K	0.87%	35
2025 Q1	$1.57M	Sell	61,971 -820	-1%	-$21.5K	0.93%	35
2024 Q4	$1.67M	Buy	+62,791	New	+$1.7M	0.98%	34

Other funds holding PFE

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

AIM

Artemis Investment Management Edinburgh, United Kingdom $11.2B AUM 80.72% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

CWP

Curated Wealth Partners El Segundo, California $774M AUM 5.71% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

DADC

D.A. Davidson & Co Great Falls, Montana $18.1B AUM 24.63% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Welch Group Birmingham, Alabama $2.93B AUM 27.62% 1-Year Est. Return

Kentucky Trust Company's PFE Position: Q2 2026 in Review

Kentucky Trust Company reduced its Pfizer (PFE) stake by 2.4% in Q2 2026, selling an estimated $41.3K and leaving 65,411 shares worth $1.58M. The position accounts for 0.76% of the portfolio, ranked #42.

Kentucky Trust Company first reported a position in PFE in Q4 2024 and has held it in 7 quarters since. The position peaked at $1.88M in Q1 2026. 900 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

Kentucky Trust Company held 65,411 shares of Pfizer worth $1.58M as of Q2 2026.
Kentucky Trust Company sold 1,579 Pfizer shares in Q2 2026, an estimated $41.3K.
Pfizer made up 0.76% of Kentucky Trust Company's portfolio in Q2 2026, its #42 holding.
Kentucky Trust Company first reported a position in Pfizer in Q4 2024 and has held it in 7 quarters since.
Kentucky Trust Company's Pfizer position peaked at $1.88M in Q1 2026.
900 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Kentucky Trust Company's 13F filing for Q2 2026, filed 10 Jul 2026.